Although biomarkers such as placental growth factor (PlGF) are used clinically to aid diagnosis in some clinical settings–particularly for preterm preeclampsia–there remains a lack of effective biomarkers to identify fetal growth restriction. Here, PGF is linked to preeclampsia.